Switzerland & Austria

Our objectives for the ISoP Swiss/Austria Chapter are as follows:

• To identify pharmacovigilance needs in Switzerland and Austria and to mobilize people and organizations to close these gaps
• To bring pharmacovigilance professionals and other key stakeholders together to better understand, promote, and raise awareness of pharmacovigilance among healthcare workers, patients, and other key stakeholders
• To provide opportunities to advocate pharmacovigilance and research across various sectors, including pharmaceuticals, biosimilars, medical devices, cosmetics, food, etc
• To stay informed about Swiss and Austrian current scientific debates and studies on patient safety
• To offer a fair and impartial venue where all parties, including patients and the industry, can ask for concerns and receive responses in a timely manner
• To assist regulatory agencies with pharmacovigilance policy guidance
• To plan and/or sponsor seminars, forums, and training in Swiss/Austrian pharmacovigilance
• To use social media and/or other communication channels to share current activities, create a venue for discussion, and inspire new research and idea
• To publish several pharmacovigilance-related topics in Switzerland and Austria in the Drug Safety Journal

The 18th ISoP Annual Meeting took place on 11th-14th November 2018 at the International Conference Centre Geneva (CICG), located near the United Nations, 10 minutes from the airport and the city centre on a convenient bus route.

The local organiser was Dr Victoria Rollason from the Hôpitaux Universitaires de Genève, and President coordinator of the ISoP Swiss Chapter.